CardioDynamics Scheduled to Present at the Gerard Klauer Mattison Healthcare Conference on April 8, 2003.Business Editors/Health/Medical Writers BIOWIRE2K SAN DIEGO--(BUSINESS WIRE)--April 7, 2003 CardioDynamics (Nasdaq: CDIC CDIC Chronic Diseases In Canada (journal) CDIC Canadian Deposit Insurance Corporation CDIC Carbon Dioxide Information Center CDIC Center for Data Intensive Computing (BNL) ), the innovator and leader of Impedance Cardiography (ICG ICG indocyanine green. ) technology and manufacturer of BioZ(R) noninvasive cardiac function monitoring systems, today announced that its CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Michael K. Perry and President, Rhonda F. Rhyne, will present at the Gerard Klauer Mattison Healthcare Conference 2003 - Focus on Oncology and Cardiology at Le Parker Meridien Hotel, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of on April 8, 2003. The company's presentation will take place in the Azekka Room at 3:00 p.m. (Eastern) and is being webcast by CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network . The webcast can be accessed live and for 90 days following the presentation at CardioDynamics' Web site http://www.cdic.com/ir/cdirf100.html. About CardioDynamics: CardioDynamics (Nasdaq: CDIC), the ICG Company, is the innovator and global leader of breakthrough medical technology called Impedance Cardiography (ICG). The company's BioZ(R) Systems are being used by leading physicians around the world to help battle the number one killer of men and women - cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease . Partners include GE Medical Systems Information Technologies, Philips Medical Systems and Vasomedical. The worldwide market potential for BioZ products is estimated to be $5 billion and an additional $800 million in recurring annual revenue for disposables. For additional information or to request an investor package, please refer to the company's Web site at www.cdic.com. Forward-Looking (Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. ) Statement: Note: Except for the historical and factual information contained herein, this press release contains forward-looking statements, such as estimated cardiovascular and ICG industry prospects, market size, potential, growth and penetration rates, the accuracy of which is necessarily subject to uncertainties and risks including the company's sole dependence on the BioZ product line, and various uncertainties characteristic of early growth companies, as well as other risks detailed in the company's filings with the SEC, including its 2002 Form 10-K. The company does not undertake to update the disclosures contained in this press release. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion